CTX-Mβ-ラクトマゼの反応座標に沿った構造,機能,抑制
Yu Chen1, Brian Shoichet, Richard Bonnet
1Department of Pharmaceutical Chemistry, University of California, San Francisco, Genentech Hall, 600 16th Street, San Francisco, California 94143-2240, USA.
Journal of the American Chemical Society
|April 14, 2005
まとめ
抗生物質耐性の主要な原因であるCTX-M酵素は,X線結晶学を用いて研究されました. 研究者らは,重要な構造的変化と新しい阻害機構を特定し,耐性細菌に対する新しい薬剤設計の道を開いた.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- 微生物学 微生物学とは
背景:
- CTX-M酵素は,拡張スペクトルベータ・ラクタメーゼ (ESBL) の重要かつ増加しているグループです.
- これらの酵素はペニシリンや様々な世代のセファロスポリンに耐性を与える.
- 効果的な阻害剤とCTX-M酵素の詳細なメカニズムに関する理解は限られている.
研究 の 目的:
- CTX-M酵素の詳細なメカニズムを解明する.
- X線結晶学を用いて酵素の反応座標を特徴付ける.
- CTX-M媒介の抗生物質耐性に対する新しい阻害剤の設計のための構造的なテンプレートを提供すること.
主な方法:
- CTX-M酵素のX線結晶構造について.
- トランジション状態のアナログとベータ・ラクタム阻害剤による複合形成.
- 反応座標に沿った酵素構成の変化の分析.
主要な成果:
- 触媒残留物Lys73とGlu166.6の形状の変化を観測した.
- セフォキシチンの7α-メトキシ群が,触媒水を移動させることによってではなく,ステリカルに脱酸化を阻害することによって抑制することを発見しました.
- CTX-M-16.6に対して4 nM K (i) の値を持つセフタジジーム類のボロン酸阻害剤を特定した.
- ボロン酸阻害剤を使用したバクテリアにおけるセフォタキシム抵抗性の逆転が実証された.
結論:
- この研究は,CTX-M酵素機構の詳細な構造的な見方を提供しています.
- この発見は,CTX-M酵素を標的とした阻害剤設計戦略の洞察を提供します.
- 構造データは,CTX-M酵素によってもたらされる抗生物質耐性に対する新しい介入の開発を導くことができます.
関連する概念動画
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


